GlaxoSmithKline (CAI:BIOC) Cyclically Adjusted FCF per Share: E£ (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is GlaxoSmithKline Cyclically Adjusted FCF per Share?

GlaxoSmithKline CAI:BIOC -2.43% Cyclically Adjusted FCF per Share is E£ as of Mar. 2025.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

GlaxoSmithKline's adjusted free cash flow per share for the three months ended in Mar. 2025 was E£1.377. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-22), GlaxoSmithKline's current stock price is E£271.12. GlaxoSmithKline's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was . GlaxoSmithKline's Cyclically Adjusted Price-to-FCF of today is .


GlaxoSmithKline  (CAI:BIOC) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


GlaxoSmithKline Cyclically Adjusted FCF per Share Related Terms


GlaxoSmithKline Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Cyclically Adjusted FCF per Share Chart

GlaxoSmithKline Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GlaxoSmithKline Quarterly Data
Jun17 Sep17 Dec17 Mar18 Sep18 Dec18 Mar19 Jun19 Sep19 Mar20 Mar21 Jun21 Sep21 Mar22 Jun22 Mar23 Jun23 Sep23 Mar24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CAI:BIOC vs PRPH: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, GlaxoSmithKline's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline's Cyclically Adjusted Price-to-FCF falls into.



GlaxoSmithKline Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GlaxoSmithKline's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.377/319.7990*319.7990
=1.377

Current CPI (Mar. 2025) = 319.7990.

GlaxoSmithKline Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201206 0.740 229.478 1.031
201209 0.000 231.407 0.000
201212 0.000 229.601 0.000
201303 -0.253 232.773 -0.348
201306 1.011 233.504 1.385
201309 0.098 234.149 0.134
201312 2.299 233.049 3.155
201403 -0.417 236.293 -0.564
201406 0.450 238.343 0.604
201409 1.107 238.031 1.487
201412 2.116 234.812 2.882
201503 -0.682 236.119 -0.924
201506 0.250 238.638 0.335
201509 0.828 237.945 1.113
201512 1.402 236.525 1.896
201603 -1.488 238.132 -1.998
201606 -0.324 241.018 -0.430
201609 0.846 241.428 1.121
201612 1.295 241.432 1.715
201703 -6.943 243.801 -9.107
201706 -0.184 244.955 -0.240
201709 -2.828 246.819 -3.664
201712 3.776 246.524 4.898
201803 0.305 249.554 0.391
201809 0.000 252.439 0.000
201812 2.614 251.233 3.327
201903 -2.111 254.202 -2.656
201906 -0.859 256.143 -1.072
201909 -0.529 256.759 -0.659
202003 -1.002 258.115 -1.241
202103 -0.312 264.877 -0.377
202106 -1.366 271.696 -1.608
202109 -0.085 274.310 -0.099
202203 -1.604 287.504 -1.784
202206 -6.817 296.311 -7.357
202303 -3.666 301.836 -3.884
202306 0.576 305.109 0.604
202309 2.750 307.789 2.857
202403 -2.546 312.332 -2.607
202503 1.377 319.799 1.377

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of E£ mean?
GlaxoSmithKline (CAI:BIOC) has a Cyclically Adjusted FCF per Share of E£ as of Mar. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's Cyclically Adjusted FCF per Share too high?
GlaxoSmithKline's current Cyclically Adjusted FCF per Share is E£.
How does GlaxoSmithKline's Cyclically Adjusted FCF per Share compare to PRPH?
GlaxoSmithKline's Cyclically Adjusted FCF per Share of E£ can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on GlaxoSmithKline and its competitors. GlaxoSmithKline's current Cyclically Adjusted FCF per Share is E£. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current Cyclically Adjusted FCF per Share of E£. The current Cyclically Adjusted FCF per Share is E£. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current Cyclically Adjusted FCF per Share is E£ as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.